biovotion non invasive physiological monitoring, continuous, wearable sensing, vital signs, parameters Multisensor, Caduff, blood oximetry perfusion, medical device
  • Biovotion selected as finalist in EU SME eHealth Competition

    2012/03/29

    Biovotion has been selected as a finalist for the EU SME eHealth Competition at the World of Health IT eHealth week 2012 conference in Copenhagen, Denmark. Biovotion will present its VSM mHealth solution on Monday 07. May, 2012.

    more

  • Biovotion completes proof of concept study for its VSM

    2012/02/23

    Biovotion shows measurements of physiological parameters with its wearable vital sign monitoring platform (VSM) in a proof of concept study

    more

  • Biovotion to present results of its wearable multi-sensor technology

    2012/02/03

    Biovotion to present results and further details about its wearable multi-sensor technology at the ATTD 2012 conference in Barcelona.

    more

  • Biovotion files new patent application

    2011/10/28

    Biovotion files new patent application in the field of vital sign monitoring

    more

  • Biovotion acquires Solianis’ sensor infrastructure

    2011/10/24

    Biovotion announces the acquisition of the Solianis’ sensor infrastructure

    more

  • Biovotion acquires Solianis IP

    2011/10/12

    Biovotion announces the acquisition of the Solianis IP portfolio.

    more

  • Incorporation Announcement

    2011/08/18

    We are happy to inform you that our time and efforts have enabled us to set up a new company.

    more

home

Biovotion AG is a medical device company providing technology and application development for the continuous and non-invasive monitoring of physiologic and/or metabolic processes.

As a first application, Biovotion AG is developing a mobile standalone wearable health monitor for continuous measurement of blood circulation parameters. Biovotion AG has provided innovation to create a proprietary technology associated with the ability to use movement to provide enhanced blood circulation parameters. This new technology will permit the measurement of vital sign parameters in real life home use conditions called the Vital Sign Monitor (VSM).

Biovotion AG will gradually develop an integrated technological platform. This platform will support partners and users with incrementally engineered further product generations based on existing technologies. Furthermore, it will permit expansion to incorporate new applications derived from continued technological innovation. Such developments will increase the scope of the Multisensor Monitoring System (MMS).

contact | impressum | print